Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Glucose Intolerance Global Clinical Trials Review, H1, 2014

Published: Apr-2014 | Format: PDF | GlobalData | Number of pages: 78 | Code: MRS - 24042


GlobalData's clinical trial report, "Glucose Intolerance Global Clinical Trials Review, H1, 2014" provides data on the Glucose Intolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Glucose Intolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Glucose Intolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Glucose Intolerance 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Glucose Intolerance 25
Subjects Recruited Over a Period of Time 26
Clinical Trials by Sponsor Type 27
Prominent Sponsors 28
Top Companies Participating in Glucose Intolerance Therapeutics Clinical Trials 29
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Merck & Co., Inc. 32
Clinical Trial Overview of Merck & Co., Inc. 32
Genfit SA 33
Clinical Trial Overview of Genfit SA 33
Novartis AG 34
Clinical Trial Overview of Novartis AG 34
N-Gene Research Laboratories, Inc. 35
Clinical Trial Overview of N-Gene Research Laboratories, Inc. 35
Laboratoires Stella SA 36
Clinical Trial Overview of Laboratoires Stella SA 36
Johnson & Johnson 37
Clinical Trial Overview of Johnson & Johnson 37
Clinical Trial Overview of Top Institutes / Government 38
Yale University 38
Clinical Trial Overview of Yale University 38
The National Institute of Diabetes and Digestive and Kidney Diseases 39
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 39
Hadassah Medical Organization 40
Clinical Trial Overview of Hadassah Medical Organization 40
Maastricht University Medical Center 41
Clinical Trial Overview of Maastricht University Medical Center 41
University of Oslo 42
Clinical Trial Overview of University of Oslo 42
Eunice Kennedy Shriver National Institute of Child Health and Human Development 43
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 43
Universite de Sherbrooke 44
Clinical Trial Overview of Universite de Sherbrooke 44
Academic Medical Center 45
Clinical Trial Overview of Academic Medical Center 45
University of Tasmania 46
Clinical Trial Overview of University of Tasmania 46
Chinese University of Hong Kong 47
Clinical Trial Overview of Chinese University of Hong Kong 47
Five Key Clinical Profiles 48
Appendix 75
Abbreviations 75
Definitions 75
Research Methodology 76
Secondary Research 76
About GlobalData 77
Contact Us 77
Disclaimer 77
Source 78

List of Tables

Glucose Intolerance Therapeutics, Global, Clinical Trials by Region, 2014* 7
Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13
Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Glucose Intolerance Therapeutics, Global, Terminated Clinical Trials, 2014* 25
Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27
Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 30
Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 32
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2014* 33
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014* 34
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by N-Gene Research Laboratories, Inc., 2014* 35
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Laboratoires Stella SA, 2014* 36
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014* 37
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2014* 38
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2014* 39
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2014* 40
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2014* 41
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Oslo, 2014* 42
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 43
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Universite de Sherbrooke, 2014* 44
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Center, 2014* 45
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tasmania, 2014* 46
Glucose Intolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 47

List of Figures

Glucose Intolerance Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Glucose Intolerance Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Glucose Intolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Glucose Intolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Glucose Intolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Glucose Intolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2014* 13
Glucose Intolerance Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Glucose Intolerance Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Glucose Intolerance to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Glucose Intolerance Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Glucose Intolerance Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Glucose Intolerance Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Glucose Intolerance Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Glucose Intolerance Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Glucose Intolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26
Glucose Intolerance Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27
Glucose Intolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28
Glucose Intolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29
Glucose Intolerance Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 31
GlobalData Methodology 76

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing